Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

The Dales Report panelists agree on this vote: Way to go, Ohio

Welcome to the Trade To Black podcast on Stockhouse.com . In the episode in the above video, Shadd Dales, Anthony Varrell and Benjamin Smith talk in-depth about the following stories and more: Ohio voters approve the legalization of adult use cannabis ...

After China Trade Deal, Trump Takes Aim at Europe

The Trump administration has taken a tough stance in international trade negotiations. With the US-China deal sealed and Congress set to vote on the US-Mexico-Canada accord, will the European Union be President Trump’s next target? Kenny Fisher ...

MAG Silver Remains Focused on Development, Exploration of Mexico Asset

A project update and the company's full-year 2018 financials were reviewed in an H.C. Wainwright & Co. report. In an April 2 research note, H.C. Wainwright & Co. analyst Heiko Ihle reported that MAG Silver Corp. (MAG:TSX; MAG:NYSE.MKT) continues to advance its jo...

FDA Approval of Antibiotic for Bacterial Pneumonia Expected in Late Summer

An update on this biopharma's two lead drug candidate programs was provided in an H.C. Wainwright report. In a May 13 research note, H.C. Wainwright & Co. analyst Ed Arce reported that for Nabriva Therapeutics Plc (NBRV:NASDAQ) , "all eyes [are] on [its] Au...

Edwards Lifesciences Gets a Charge on Positive Q2 Earnings Report

Edwards Lifesciences is trading higher after reporting higher than expected adjusted earnings for Q2/19. The company estimates that the FDA will approve its SAPIEN 3 valve and SAPIEN 3 Ultra system in Q3/19. Structural heart disease and critical care monitor...

FDA Approval of Biopharma's Pain Drug Expected This Year

The reasons a green light is anticipated and how it relates to the closing of Avenue Therapeutics' pending acquisition are discussed in an H.C. Wainwright & Co. report. In a Feb. 13 research note, H.C. Wainwright & Co. analyst Ed Arce reported that the U.S. ...

Cabral Sitting on a Plateau of Gold

I fully approve of garimpeiro miners. Rarely can they read and write. They can live under conditions that the majority of us could never handle. They mine in a totally different way than do the junior resource companies in the space. They all make money. That's right, 100...

Cannabis testing: the new frontier

The legalization of cannabis in Canada was heralded by growers, dispensaries and users throughout the country, some of whom had been calling for an end to the prohibition of cannabis for years. What many had not anticipated was the need for a rigorous system for tes...

Biopharma Expected to Bring 'Two First-in-Class Antibiotics to Market in 2019'

The likely timelines for approval and commercialization of each drug are discussed in an H.C. Wainwright report. In a March 13 research note, H.C. Wainwright & Co. analyst Ed Arce reported that Nabriva Therapeutics Plc (NBRV:NASDAQ) has two antibiotics up for approval...

Teekay Offshore Shares Spike 30% Higher on Brookfield Merger Agreement

Teekay Offshore Partners shares are trading more than 30% higher today on news that Brookfield Business Partners will be purchasing all un-owned common units of the firm for $1.55 per share. This morning Hamilton, Bermuda based Teekay Offshore Partners L.P. (TOO:NYSE...
1 2 3